Caroline Gaudy-Marqueste1, Yanal Wazaefi2, Yvane Bruneu1, Raoul Triller3, Luc Thomas4, Giovanni Pellacani5, Josep Malvehy6, Marie-Françoise Avril7, Sandrine Monestier1, Marie-Aleth Richard1, Bernard Fertil2, Jean-Jacques Grob1. 1. Dermatology and Skin Cancer Department, Hôpital Timone, Marseille, France. 2. Laboratory of Sciences of Information and Systems, Aix-Marseille University, Marseille, France. 3. Department of Dermatology, The Hertford British Hospital Charity, Levallois-Perret, France. 4. Department of Dermatology, Lyon Sud Hospital, Pierre Bénite, France. 5. Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy. 6. Department of Dermatology, Hospital Clinic of Barcelona, Barcelona, Spain. 7. Department of Dermatology, Assistance Publique des Hôpitaux de Paris, Hospital Cochin, University Paris Descartes, Paris, France.
Abstract
Importance: Understanding the contribution of the ugly duckling sign (a nevus that is obviously different from the others in a given individual) in intrapatient comparative analysis (IPCA) of nevi may help improve the detection of melanoma. Objectives: To assess the agreement of dermatologists on identification of the ugly duckling sign and estimate the contribution of IPCA to the diagnosis of melanoma. Design, Setting, and Participants: The same 2089 digital images of the nevi of a sample of 80 patients (mean age, 42 years [range, 19-80 years]; 33 men and 47 women), as well as 766 dermoscopic images from a subset of 30 patients (mean age, 40 years [range, 21-75 years]; 12 men and 18 women), were randomly presented to the same 9 dermatologists for blinded assessment from September 22, 2011, to April 1, 2013. The first experiment was designed to mimic an IPCA situation, with images of all nevi of each patient shown to the dermatologists, who were asked to identify ugly duckling nevi (UDN). The second experiment was designed to mimic a lesion-focused analysis to identify morphologically suspicious nevi. Data analysis was conducted from November 1, 2012, to June 1, 2013. Main Outcomes and Measures: Number of nevi labeled UDN and morphologically suspicious nevi, specificity of lesion-focused analysis and IPCA, and number of nevi identified for biopsy. Results: Of the 2089 clinical images of nevi from 80 patients (median number of nevi per patient, 26 [range, 8-81]) and 766 dermoscopic images (median number of nevi per patient, 19 [range, 8-81]), all melanomas were labeled UDN and as morphologically suspicious nevi by the 9 dermatologists. The median number of UDN detected per patient was 0.8 among the clinical images of nevi (mean, 1.0; range, 0.48-2.03) and 1.26 among the dermoscopic images (mean, 1.4; range, 1.00-2.06). The propensity to consider more or fewer nevi as having ugly duckling signs was independent of the presentation (clinical or dermoscopic). The agreement among the dermatologists regarding UDN was lower with dermoscopic images (mean pairwise agreement, 0.53 for clinical images and 0.50 for dermoscopic images). The specificity of IPCA was 0.96 for clinical images and 0.95 for dermoscopic images vs 0.88 and 0.85, respectively, for lesion-focused analysis. When both IPCA and lesion-focused analyses were used, the number of nevi considered for biopsy was reduced by a factor of 6.9 compared with lesion-focused analysis alone. Conclusions and Relevance: Intrapatient comparative analysis is of major importance to the effectiveness of the diagnosis of melanoma. Introducing IPCA using the ugly duckling sign in computer-assisted diagnosis systems would be expected to improve performance.
Importance: Understanding the contribution of the ugly duckling sign (a nevus that is obviously different from the others in a given individual) in intrapatient comparative analysis (IPCA) of nevi may help improve the detection of melanoma. Objectives: To assess the agreement of dermatologists on identification of the ugly duckling sign and estimate the contribution of IPCA to the diagnosis of melanoma. Design, Setting, and Participants: The same 2089 digital images of the nevi of a sample of 80 patients (mean age, 42 years [range, 19-80 years]; 33 men and 47 women), as well as 766 dermoscopic images from a subset of 30 patients (mean age, 40 years [range, 21-75 years]; 12 men and 18 women), were randomly presented to the same 9 dermatologists for blinded assessment from September 22, 2011, to April 1, 2013. The first experiment was designed to mimic an IPCA situation, with images of all nevi of each patient shown to the dermatologists, who were asked to identify ugly duckling nevi (UDN). The second experiment was designed to mimic a lesion-focused analysis to identify morphologically suspicious nevi. Data analysis was conducted from November 1, 2012, to June 1, 2013. Main Outcomes and Measures: Number of nevi labeled UDN and morphologically suspicious nevi, specificity of lesion-focused analysis and IPCA, and number of nevi identified for biopsy. Results: Of the 2089 clinical images of nevi from 80 patients (median number of nevi per patient, 26 [range, 8-81]) and 766 dermoscopic images (median number of nevi per patient, 19 [range, 8-81]), all melanomas were labeled UDN and as morphologically suspicious nevi by the 9 dermatologists. The median number of UDN detected per patient was 0.8 among the clinical images of nevi (mean, 1.0; range, 0.48-2.03) and 1.26 among the dermoscopic images (mean, 1.4; range, 1.00-2.06). The propensity to consider more or fewer nevi as having ugly duckling signs was independent of the presentation (clinical or dermoscopic). The agreement among the dermatologists regarding UDN was lower with dermoscopic images (mean pairwise agreement, 0.53 for clinical images and 0.50 for dermoscopic images). The specificity of IPCA was 0.96 for clinical images and 0.95 for dermoscopic images vs 0.88 and 0.85, respectively, for lesion-focused analysis. When both IPCA and lesion-focused analyses were used, the number of nevi considered for biopsy was reduced by a factor of 6.9 compared with lesion-focused analysis alone. Conclusions and Relevance: Intrapatient comparative analysis is of major importance to the effectiveness of the diagnosis of melanoma. Introducing IPCA using the ugly duckling sign in computer-assisted diagnosis systems would be expected to improve performance.
Authors: Philipp Tschandl; Noel Codella; Bengü Nisa Akay; Giuseppe Argenziano; Ralph P Braun; Horacio Cabo; David Gutman; Allan Halpern; Brian Helba; Rainer Hofmann-Wellenhof; Aimilios Lallas; Jan Lapins; Caterina Longo; Josep Malvehy; Michael A Marchetti; Ashfaq Marghoob; Scott Menzies; Amanda Oakley; John Paoli; Susana Puig; Christoph Rinner; Cliff Rosendahl; Alon Scope; Christoph Sinz; H Peter Soyer; Luc Thomas; Iris Zalaudek; Harald Kittler Journal: Lancet Oncol Date: 2019-06-12 Impact factor: 41.316
Authors: Katarzyna Grochulska; Brigid Betz-Stablein; Chantal Rutjes; Frank Po-Chao Chiu; Scott W Menzies; H Peter Soyer; Monika Janda Journal: Dermatology Date: 2021-08-11 Impact factor: 5.366
Authors: Yao Zhang; Kamil Ali; Jacob A George; Jason S Reichenberg; Matthew C Fox; Adewole S Adamson; James W Tunnell; Mia K Markey Journal: J Med Imaging (Bellingham) Date: 2021-02-10
Authors: C Longo; V Barquet; E Hernandez; A A Marghoob; M Potrony; C Carrera; P Aguilera; C Badenas; J Malvehy; S Puig Journal: J Eur Acad Dermatol Venereol Date: 2020-07-28 Impact factor: 9.228